Browsing by Author "Moya, Pablo R."

Now showing items 1-4 of 4

    • Di erences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and ... 
      Acuña Castillo, Claudio; Villalobos, Claudio; Moya, Pablo R.; Sáez, Patricio; Cassels Niven, Bruce; Huidobro Toro, Juan Pablo (Nature Publishing Group, 2002-04-04)
      1 The pharmacological pro®le of a series of (+)-2,5-dimethoxy-4-(X)-phenylisopropylamines (X=I, Br, NO2, CH3, or H) and corresponding phenylethylamines, was determined in Xenopus laevis oocytes injected with cRNA coding ...
    • Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human ... 
      Moya, Pablo R.; Berg, Kelly A.; Gutiérrez Hernández, Manuel A.; Sáez Briones, Patricio; Reyes Parada, Miguel; Cassels Niven, Bruce; Clarke, William P. (2007)
      2,5-Dimethoxy-4-substituted phenylisopropylamines and phenethylamines are 5-hydroxytryptamine (serotonin) (5-HT)(2A/2C) agonists. The former are partial to full agonists, whereas the latter are partial to weak agonists. ...
    • Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human ... 
      Moya, Pablo R.; Berg, Kelly A.; Gutiérrez Hernández, Manuel A.; Sáez Briones, Patricio; Reyes Parada, Miguel; Cassels Niven, Bruce; Clarke, William P. (The American Society for Pharmacology and Experimental Therapeutics, 2007-02-28)
      2,5-Dimethoxy-4-substituted phenylisopropylamines and phenethylamines are 5-hydroxytryptamine (serotonin) (5-HT)2A/2C agonists. The former are partial to full agonists, whereas the latter are partial to weak agonists. ...
    • Improving Amphetamine Therapeutic Selectivity: N,N-dimethyl-MTA has Dopaminergic Effects and does not Produce ... 
      Sotomayor Zárate, Ramón; Jara, Pablo; Araos, Patricio; Vinet, Raúl; Quiróz, Gabriel; Renard, Georgina M.; Espinosa, Pedro; Hurtado Guzmán, Claudio; Moya, Pablo R.; Iturriaga-Vásquez, Patricio; Gysling, Katia; Reyes Parada, Miguel (Nordic Pharmacological Society), 2014)
      Abstract: Amphetamine derivatives have therapeutic potential in diseases such as attention deficit hyperactivity disorder, narcolepsy and obesity. However, their prolonged use has been associated with cardiovascular ...